- Home
- CDIO vs AUST Comparison
CDIO vs AUST Comparison
Compare CDIO & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- AUST
- Stock Information
- Founded
- CDIO 2017
- AUST 2020
- Country
- CDIO United States
- AUST Canada
- Employees
- CDIO N/A
- AUST N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- AUST
- Sector
- CDIO Health Care
- AUST
- Exchange
- CDIO Nasdaq
- AUST Nasdaq
- Market Cap
- CDIO 19.5M
- AUST 18.0M
- IPO Year
- CDIO N/A
- AUST 2022
- Fundamental
- Price
- CDIO $0.48
- AUST $1.23
- Analyst Decision
- CDIO Buy
- AUST
- Analyst Count
- CDIO 1
- AUST 0
- Target Price
- CDIO $2.00
- AUST N/A
- AVG Volume (30 Days)
- CDIO 763.1K
- AUST 124.3K
- Earning Date
- CDIO 05-14-2025
- AUST 05-07-2025
- Dividend Yield
- CDIO N/A
- AUST N/A
- EPS Growth
- CDIO N/A
- AUST N/A
- EPS
- CDIO N/A
- AUST N/A
- Revenue
- CDIO $34,890.00
- AUST N/A
- Revenue This Year
- CDIO $1,434.82
- AUST N/A
- Revenue Next Year
- CDIO $4,661.91
- AUST N/A
- P/E Ratio
- CDIO N/A
- AUST N/A
- Revenue Growth
- CDIO 104.45
- AUST N/A
- 52 Week Low
- CDIO $0.19
- AUST $0.79
- 52 Week High
- CDIO $1.77
- AUST $3.19
- Technical
- Relative Strength Index (RSI)
- CDIO 68.01
- AUST 44.12
- Support Level
- CDIO $0.30
- AUST $1.13
- Resistance Level
- CDIO $0.43
- AUST $1.44
- Average True Range (ATR)
- CDIO 0.06
- AUST 0.14
- MACD
- CDIO 0.02
- AUST -0.01
- Stochastic Oscillator
- CDIO 90.15
- AUST 28.33
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About AUST Austin Gold Corp.
Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).